Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Portopulmonary hypertension

Findlay JY, Plevak DJ, Krowka MJ, Sack EM, Porayko MK. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg 1999 5(5) 362-5. [Pg.120]

This clinical picture was described for the first time in 1951 by F. Mantz et al. (65) and confirmed in 1983 by P.J. McDonnell et al. Portopulmonary hypertension (PPH) is defined as a secondary form of pulmonary hypertension with portal hypertension. Frequency in patients with cirrhosis is given as 2-4%, in patients in an advanced stage of cirrhosis (e.g. presenting for liver transplantation) as 5-10% of cases, (s. pp 258, 735)... [Pg.337]

Diagnosis of portopulmonary hypertension in candidates for liver transplantation a prospective study. Hepatology 2003 37 401-409... [Pg.340]

Kahler, C.M., Graziadei, I., Wiedermann, C.X, Kneussl, M.P., Vogel, W. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension. Wien. Klin. Wschr. 2000 112 637-640... [Pg.340]

Krowka, M.X, Frantz, R.P., McGoon, M.D., Severson, C., Plevak, D.X, Wiesner, R.H. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin) a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 1999 30 641-648... [Pg.340]

Krowka, M.X Hepatopulmonary hypertension and portopulmonary hypertension distinctions and dilemmas. Hepatology 1997 25 1282—1284... [Pg.340]

L. R., Johnson, L.B. Portopulmonary hypertension and the liver transplant candidate. Transplantation 1999 67 1087-1093... [Pg.340]

Portopulmonary hypertension (PPH) Liver cirrhosis Chronic hepatitis Schistosomiasis Alagille s syndrome Hypoplastic portal vein Multifoc. nod. hyperplasia... [Pg.734]

Portopulmonary hypertension (PPH) is characterized by (1.) elevated pulmonary artery pressure (>25 mm Hg), (2.) increased pulmonary vascular resistance (>120 dyne/sec/cm ), and (3.) normal pulmonary capillary wedge pressure (<15 mm Hg). The presence of portal hypertension is considered to be a prerequisite for the development of PPH. [Pg.735]

Roberts KE, Fallon MB, Krowka MJ, et al. Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest 2009 135(6) 1470-5. [Pg.161]

See other pages where Portopulmonary hypertension is mentioned: [Pg.399]    [Pg.412]    [Pg.119]    [Pg.258]    [Pg.333]    [Pg.337]    [Pg.340]    [Pg.340]    [Pg.340]    [Pg.715]    [Pg.151]    [Pg.424]   


SEARCH



© 2024 chempedia.info